CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
+5.32%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$2.57B
AUM Growth
+$2.57B
(-0.63%)
Cap. Flow
-$170M
Cap. Flow
% of AUM
-6.58%
Top 10 Holdings %
Top 10 Hldgs %
65.46%
Holding
41
New
4
Increased
7
Reduced
8
Closed
7
Top Buys
| 1 |
Ascendis Pharma
ASND
|
$105M |
| 2 |
Sarepta Therapeutics
SRPT
|
$78.1M |
| 3 |
Zimmer Biomet
ZBH
|
$62.1M |
| 4 |
Medtronic
MDT
|
$45M |
| 5 |
CON
Concentra Group Holdings Parent, Inc.
CON
|
$44.2M |
Top Sells
| 1 |
Universal Health Services
UHS
|
$189M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$90.6M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
$84.7M |
| 4 |
Humana
HUM
|
$63.3M |
| 5 |
Myriad Genetics
MYGN
|
$42.5M |
Sector Composition
| 1 | Healthcare | 98.18% |
| 2 | Consumer Staples | 0.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Zimmer Biomet
ZBH
$21B
| $270M | 8.57% | 2,500,000 +575,000 | +30% | +$62.1M |
|
|
2
Medtronic
MDT
$119B
| $248M | 7.86% | 2,750,000 +500,000 | +22% | +$45M |
|
3
Baxter International
BAX
$12.7B
| $247M | 7.84% | 6,500,000 +1,000,000 | +18% | +$38M |
|
4
Viatris
VTRS
$12.3B
| $174M | 5.53% | 15,000,000 | – | – |
|
5
Globus Medical
GMED
$8.27B
| $154M | 4.89% | 2,150,000 -350,000 | -14% | -$25M |
|
6
PTC Therapeutics
PTCT
$3.92B
| $130M | 4.12% | 3,500,000 | – | – |
|
7
Jazz Pharmaceuticals
JAZZ
$7.75B
| $128M | 4.07% | 1,150,000 | – | – |
|
8
GSK
GSK
$79.9B
| $123M | 3.9% | 3,000,000 +325,000 | +12% | +$13.3M |
|
|
9
Myriad Genetics
MYGN
$593M
| $108M | 3.44% | 3,950,000 -1,550,000 | -28% | -$42.5M |
|
|
10
Ascendis Pharma
ASND
$11.8B
| $105M | 3.32% | +700,000 | New | +$105M |
|
|
11
Sarepta Therapeutics
SRPT
$1.78B
| $96.8M | 3.07% | 775,000 +625,000 | +417% | +$78.1M |
|
12
Brookdale Senior Living
BKD
$1.83B
| $94.6M | 3.01% | 13,935,000 -1,565,000 | -10% | -$10.6M |
|
13
CVS Health
CVS
$92.8B
| $94.3M | 3% | 1,500,000 | – | – |
|
14
Select Medical
SEM
$1.61B
| $74.1M | 2.35% | 2,125,000 -425,000 | -17% | -$14.8M |
|
15
Qiagen
QGEN
$10.1B
| $68.4M | 2.17% | 1,500,000 | – | – |
|
|
16
Humana
HUM
$36.5B
| $63.3M | 2.01% | 200,000 -200,000 | -50% | -$63.3M |
|
17
Denali Therapeutics
DNLI
$2.23B
| $58.3M | 1.85% | 2,000,000 | – | – |
|
|
CON
18
Concentra Group Holdings Parent, Inc.
CON
$3.05B
| $44.2M | 1.4% | +1,975,000 | New | +$44.2M |
|
19
ZimVie
ZIMV
$532M
| $43.2M | 1.37% | 2,725,000 -525,000 | -16% | -$8.33M |
|
20
Medpace
MEDP
$13.4B
| $41.7M | 1.33% | +125,000 | New | +$41.7M |
|
21
Evolent Health
EVH
$1.12B
| $39.6M | 1.26% | 1,400,000 +775,000 | +124% | +$21.9M |
|
|
22
Universal Health Services
UHS
$11.6B
| $28.6M | 0.91% | 125,000 -825,000 | -87% | -$189M |
|
|
BKDT
23
DELISTED
Brookdale Senior Living Inc. 7.00% Tangible Equity Units
BKDT
| $23.1M | 0.73% | 250,000 | – | – |
|
24
MoonLake Immunotherapeutics
MLTX
$3.54B
| $22.2M | 0.71% | 441,000 +86,000 | +24% | +$4.34M |
|
25
Herbalife
HLF
$1.01B
| $21.6M | 0.69% | 3,000,000 | – | – |
|